MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - pharmaceuticals
- TTK HEALTHCARE - TEVA PHARMA (Israel)
TTK HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 TTK HEALTHCARE  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| TTK HEALTHCARE Mar-19 |
TEVA PHARMA Dec-13 |
TTK HEALTHCARE/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 1,215 | 3,117 | - | |
| Low | Rs | 610 | 2,708 | - | |
| Sales per share (Unadj.) | Rs | 444.4 | 1,788.7 | - | |
| Earnings per share (Unadj.) | Rs | 17.2 | 111.7 | - | |
| Cash flow per share (Unadj.) | Rs | 27.6 | 256.3 | - | |
| Dividends per share (Unadj.) | Rs | 5.00 | 97.82 | - | |
| Dividend yield (eoy) | % | 0.5 | 3.4 | 16.3% | |
| Book value per share (Unadj.) | Rs | 177.9 | 1,986.9 | - | |
| Shares outstanding (eoy) | m | 14.13 | 848.00 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 2.1 | 1.6 | 126.1% | |
| Avg P/E ratio | x | 52.9 | 26.1 | 203.0% | |
| P/CF ratio (eoy) | x | 33.0 | 11.4 | 290.7% | |
| Price / Book Value ratio | x | 5.1 | 1.5 | 349.9% | |
| Dividend payout | % | 29.0 | 87.5 | 33.1% | |
| Avg Mkt Cap | Rs m | 12,894 | 2,469,486 | 0.5% | |
| No. of employees | `000 | 2.3 | 44.9 | 5.1% | |
| Total wages/salary | Rs m | 1,307 | 0 | - | |
| Avg. sales/employee | Rs Th | 2,715.7 | 33,748.9 | 8.0% | |
| Avg. wages/employee | Rs Th | 565.3 | 0 | - | |
| Avg. net profit/employee | Rs Th | 105.4 | 2,108.3 | 5.0% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 6,279 | 1,516,846 | 0.4% | |
| Other income | Rs m | 78 | 0 | - | |
| Total revenues | Rs m | 6,356 | 1,516,846 | 0.4% | |
| Gross profit | Rs m | 496 | 415,389 | 0.1% | |
| Depreciation | Rs m | 147 | 122,608 | 0.1% | |
| Interest | Rs m | 34 | 29,793 | 0.1% | |
| Profit before tax | Rs m | 393 | 262,988 | 0.1% | |
| Minority Interest | Rs m | 0 | 1,195 | 0.0% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | -172,637 | 0.0% | |
| Tax | Rs m | 149 | -3,211 | -4.6% | |
| Profit after tax | Rs m | 244 | 94,756 | 0.3% | |
| Gross profit margin | % | 7.9 | 27.4 | 28.8% | |
| Effective tax rate | % | 37.9 | -1.2 | -3,106.5% | |
| Net profit margin | % | 3.9 | 6.2 | 62.1% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 2,717 | 1,024,472 | 0.3% | |
| Current liabilities | Rs m | 1,571 | 893,427 | 0.2% | |
| Net working cap to sales | % | 18.3 | 8.6 | 211.3% | |
| Current ratio | x | 1.7 | 1.1 | 150.9% | |
| Inventory Days | Days | 32 | 91 | 35.4% | |
| Debtors Days | Days | 47 | 96 | 48.6% | |
| Net fixed assets | Rs m | 991 | 495,435 | 0.2% | |
| Share capital | Rs m | 141 | 3,734 | 3.8% | |
| Net worth | Rs m | 2,514 | 1,684,929 | 0.1% | |
| Long term debt | Rs m | 3 | 775,597 | 0.0% | |
| Total assets | Rs m | 4,158 | 3,466,480 | 0.1% | |
| Interest coverage | x | 12.6 | 9.8 | 128.4% | |
| Debt to equity ratio | x | 0 | 0.5 | 0.3% | |
| Sales to assets ratio | x | 1.5 | 0.4 | 345.1% | |
| Return on assets | % | 6.7 | 3.6 | 185.7% | |
| Return on equity | % | 9.7 | 5.6 | 172.4% | |
| Return on capital | % | 16.9 | 4.9 | 343.4% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 173 | 241,707 | 0.1% | |
| From Investments | Rs m | 97 | -85,646 | -0.1% | |
| From Financial Activity | Rs m | -307 | -289,944 | 0.1% | |
| Net Cashflow | Rs m | -38 | -133,883 | 0.0% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.67 Rs / USD
Compare TTK HEALTHCARE With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare TTK HEALTHCARE With: SUN PHARMA NATCO PHARMA IPCA LABS STRIDES PHARMA SCIENCE VENUS REMEDIES
Today's Market
Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)
Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.
Related Views On News
TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)
Feb 5, 2021 | Updated on Feb 5, 2021For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)
Jan 30, 2020 | Updated on Jan 30, 2020For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.
TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)
Jul 18, 2019 | Updated on Jul 18, 2019Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.
More Views on NewsMost Popular
A Critical Update on the Market (Fast Profits Daily)
Mar 30, 2021In this video, I'll tell you why I am recommending caution in the market at this time.
My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)
Mar 31, 2021A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
My Stock Trading Strategy (Fast Profits Daily)
Mar 31, 2021In this video I'll show you exactly how I go about picking stocks for trading.
What You Need to Find Hundred Baggers (Profit Hunter)
Mar 30, 2021100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More
